Neuberger Berman Group LLC Lowers Position in Humana Inc. (NYSE:HUM)

Neuberger Berman Group LLC decreased its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 69.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 144,980 shares of the insurance provider's stock after selling 328,088 shares during the period. Neuberger Berman Group LLC owned about 0.12% of Humana worth $36,783,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Colonial Trust Advisors grew its holdings in shares of Humana by 4,500.0% during the fourth quarter. Colonial Trust Advisors now owns 184 shares of the insurance provider's stock valued at $47,000 after purchasing an additional 180 shares during the last quarter. Scotia Capital Inc. increased its stake in Humana by 44.2% in the 4th quarter. Scotia Capital Inc. now owns 953 shares of the insurance provider's stock worth $242,000 after purchasing an additional 292 shares in the last quarter. Bessemer Group Inc. raised its holdings in shares of Humana by 2.0% during the fourth quarter. Bessemer Group Inc. now owns 6,518 shares of the insurance provider's stock valued at $1,655,000 after acquiring an additional 125 shares during the period. Raymond James Financial Inc. purchased a new stake in shares of Humana in the fourth quarter valued at $26,720,000. Finally, APG Asset Management N.V. grew its stake in Humana by 230.0% during the 4th quarter. APG Asset Management N.V. now owns 86,229 shares of the insurance provider's stock valued at $21,127,000 after acquiring an additional 60,098 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on HUM. Piper Sandler increased their price objective on Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a report on Wednesday, January 15th. Robert W. Baird boosted their price objective on Humana from $270.00 to $300.00 and gave the company a "neutral" rating in a research report on Tuesday. Truist Financial boosted their price target on Humana from $290.00 to $325.00 and gave the company a "hold" rating in a research note on Friday, April 11th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $283.00 price objective on shares of Humana in a report on Wednesday, February 12th. Finally, Guggenheim assumed coverage on Humana in a research note on Wednesday, April 9th. They set a "buy" rating and a $326.00 price objective on the stock. Seventeen investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $284.90.

Humana Trading Up 0.4 %

NYSE:HUM traded up $1.10 during midday trading on Wednesday, hitting $287.88. 381,425 shares of the company traded hands, compared to its average volume of 1,745,686. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm's fifty day moving average is $265.57 and its 200-day moving average is $270.22. The firm has a market capitalization of $34.75 billion, a P/E ratio of 28.93, a P/E/G ratio of 2.05 and a beta of 0.62.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, sell-side analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a $0.885 dividend. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.23%. Humana's dividend payout ratio (DPR) is currently 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.